Deep Brain Stimulation Clinical Trials

Clinical trials related to Deep Brain Stimulation Procedure

Basal Ganglia Contributions to Transitions in Freezing of Gait and Parkinson's Disease

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this research is to examine the possible causes and signs of freezing of gait (FOG) secondary to Parkinson's disease (PD). To achieve this, the study will use the novel (on-label and FDA-approved) local field potential (LFP) measuring capability of the Medtronic Percept™ deep brain stimulation (DBS) system to compare oscillatory activity in people who have Parkinson's disease, with and without freezing of gait (FOG). This will be conducted as three separate experiments, participants may volunteer for one or more experiments: Experiment 1: The first experiment will compare LFPs during gait initiation with and without a cue, in people with (PD+FOG) and without FOG (PD-FOG). Experiment 2: The second experiment will compare LFPs during the successful movement transitions vs. freezing-events during a FOG provocation course in people with FOG. Experiment 3: The third experiment will compare LFPs during rapid alternating movements of the wrist and/or foot, in people with and without FOG

Eligibility
Participation Requirements
Sex: All
Minimum Age: 21
Maximum Age: 75
Healthy Volunteers: f
View:

• Diagnosis of idiopathic PD.

• Age 21-75 (see Inclusion of Individuals across the Lifespan for justification of age range).

• Able to ambulate independently without the use of an assistive device (e.g. cane) for 50 meters.

• Implanted Medtronic Percept TM Device.

• At least 3 months since the initial activation of the neurostimulator.

• Undervalued, under-represented, or disenfranchised social group may be included.

• Active members of the military (service members), DoD personnel (including civilian employees) may be included.

• Individual or group that is disadvantaged in the distribution of social goods and services such as income, housing, or healthcare may be included.

Locations
United States
Minnesota
University of Minnesota, Movement Disorders Lab
RECRUITING
Minneapolis
Contact Information
Primary
Madison Aasen, MS
aasen056@umn.edu
612-505-8325
Backup
Sommer Amundsen-Huffmaster, PhD
slamunds@umn.edu
612-301-1297
Time Frame
Start Date: 2026-02-26
Estimated Completion Date: 2029-01-01
Participants
Target number of participants: 36
Treatments
Experimental: Parkinson's disease with freezing of gait
Participants will have a Medtronic Percept DBS device, diagnosis of idiopathic Parkinson's disease (PD), and freezing of gait (FOG).
Experimental: Parkinson's disease without freezing of gait
Participants will have a Medtronic Percept DBS device and diagnosis of idiopathic Parkinson's disease (PD) without having freezing of gait (FOG).~Participants in this arm will not be tested in experiment #2.
Sponsors
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS)
Leads: University of Minnesota

This content was sourced from clinicaltrials.gov